Skip to main content
SpringerLink
Log in

STEM CELLS

The reprogramming method matters

  • News & Views
  • Published:

From Nature Biomedical Engineering

View current issue Submit your manuscript

A Publisher Correction to this article was published on 02 January 2018

This article has been updated

The genetic, epigenetic and transcriptomic profiles of human induced pluripotent stem cells are shaped by the reprogramming route.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1: hiPSCs generated by different reprogramming methods have distinct genetic, epigenetic and transcriptomic patterns from one another and from hESCs.

Change history

  • 02 January 2018

    In the version of this News and Views article originally published, an erroneous hyphen was included in the term ‘human-induced pluripotent stem cells’; it should have read ‘human induced pluripotent stem cells’. This error has now been corrected in all versions of the News and Views article.

References

  1. Takahashi, K. et al. Cell 131, 861–872 (2007).

    Article  CAS  PubMed  Google Scholar 

  2. Bock, C. et al. Cell 144, 439–452 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Chin, M., Mason, M., Xie, W., Volinia, S. & Singer, M. Cell Stem Cell 5, 111–123 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Ruiz, S. et al. Proc. Natl Acad. Sci. USA 109, 16196–16201 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Churko, J. M. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-017-0141-6 (2017).

    Article  Google Scholar 

  6. Amps, K. et al. Nat. Biotech 29, 1132–1144 (2011).

    Article  CAS  Google Scholar 

  7. Baker, D. et al. Stem Cell Rep 7, 998–1012 (2016).

    Article  CAS  Google Scholar 

  8. Huangfu, D. et al. Nat. Biotechnol. 26, 795–797 (2008).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, 90095, USA

    Thomas F. Allison

  2. Department of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, Los Angeles, CA, 90095, USA

    Thomas F. Allison & William E. Lowry

  3. Molecular Biology Institute, University of California, Los Angeles, Los Angeles, CA, 90095, USA

    William E. Lowry

  4. Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, Los Angeles, CA, 90095, USA

    Thomas F. Allison & William E. Lowry

  5. Department of Dermatology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, 90095, USA

    William E. Lowry

  6. Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, 90095, USA

    William E. Lowry

Authors
  1. Thomas F. Allison
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. William E. Lowry
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William E. Lowry.

Additional information

A correction to this article is available online at https://doi.org/10.1038/s41551-017-0170-1.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Allison, T.F., Lowry, W.E. The reprogramming method matters. Nat Biomed Eng 1, 779–781 (2017). https://doi.org/10.1038/s41551-017-0148-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41551-017-0148-z

  • Springer Nature Limited

Search

Navigation